TY - JOUR
T1 - The elicitation step of nickel allergy is promoted in mice by microbe-related substances, including some from oral bacteria
AU - Huang, Ling
AU - Kinbara, Masayuki
AU - Funayama, Hiromi
AU - Takada, Haruhiko
AU - Sugawara, Shunji
AU - Endo, Yasuo
N1 - Funding Information:
We are grateful to Dr. R. Timms for editing the manuscript. This work was supported by Grants-in Aid from the Japan Society for the Promotion of Science (nos. 18591995 and 21659442 ).
PY - 2011/11
Y1 - 2011/11
N2 - Microbial components activate the host's innate immunity via interactions with molecules including TLRs and NODs. We previously reported that in mice (i) Escherichia coli lipopolysaccharide (LPS; TLR4 agonist) promotes Ni-allergy even in T-cell-deficient mice, (ii) E. coli LPS reduces the minimum allergy-inducing concentrations of Ni at both the sensitization and elicitation steps, and (iii) various microbe-related substances promote sensitization to Ni. Here, we examined the effects of microbe-related substances at the elicitation step. Mice (except for TLR4-mutated C3H/HeJ mice) were sensitized to Ni by intraperitoneal injection of NiCl 2 + E. coli LPS. Ten days later their ear-pinnas were challenged with 1 μM NiCl 2 with or without a test substance. Although NiCl 2 alone at this concentration does not induce Ni-allergy, its combination with the following substances induced Ni-allergy in BALB/c mice: LPS preparations from oral Gram-negative bacteria (Prevotella intermedia and Porphyromonas gingivalis), a mannan preparation from a fungus (Saccharomyces cerevisiae), and synthetic NOD2 and TLR2 agonists. The effect of the mannan preparation was small in C3H/HeJ mice (sensitized with NiCl 2 + the P. intermedia preparation). The P. intermedia preparation promoted Ni-allergy in C3H/HeJ and nude mice, but not in mice deficient in either TLR2 or histidine decarboxylase. Intragingival injection of the P. intermedia preparation and later challenge with NiCl 2 alone to ear-pinnas also promoted Ni-allergy. These results indicate that (i) in Ni-allergy, a microbial milieu or innate immunity is important at the elicitation step, too, and (ii) some oral bacteria may promote Ni-allergy via TLR2-stimulant(s) production.
AB - Microbial components activate the host's innate immunity via interactions with molecules including TLRs and NODs. We previously reported that in mice (i) Escherichia coli lipopolysaccharide (LPS; TLR4 agonist) promotes Ni-allergy even in T-cell-deficient mice, (ii) E. coli LPS reduces the minimum allergy-inducing concentrations of Ni at both the sensitization and elicitation steps, and (iii) various microbe-related substances promote sensitization to Ni. Here, we examined the effects of microbe-related substances at the elicitation step. Mice (except for TLR4-mutated C3H/HeJ mice) were sensitized to Ni by intraperitoneal injection of NiCl 2 + E. coli LPS. Ten days later their ear-pinnas were challenged with 1 μM NiCl 2 with or without a test substance. Although NiCl 2 alone at this concentration does not induce Ni-allergy, its combination with the following substances induced Ni-allergy in BALB/c mice: LPS preparations from oral Gram-negative bacteria (Prevotella intermedia and Porphyromonas gingivalis), a mannan preparation from a fungus (Saccharomyces cerevisiae), and synthetic NOD2 and TLR2 agonists. The effect of the mannan preparation was small in C3H/HeJ mice (sensitized with NiCl 2 + the P. intermedia preparation). The P. intermedia preparation promoted Ni-allergy in C3H/HeJ and nude mice, but not in mice deficient in either TLR2 or histidine decarboxylase. Intragingival injection of the P. intermedia preparation and later challenge with NiCl 2 alone to ear-pinnas also promoted Ni-allergy. These results indicate that (i) in Ni-allergy, a microbial milieu or innate immunity is important at the elicitation step, too, and (ii) some oral bacteria may promote Ni-allergy via TLR2-stimulant(s) production.
KW - Innate immunity
KW - Lipopolysaccharide
KW - Mannan
KW - Nickel allergy
KW - Oral bacteria
UR - http://www.scopus.com/inward/record.url?scp=80055020911&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=80055020911&partnerID=8YFLogxK
U2 - 10.1016/j.intimp.2011.07.025
DO - 10.1016/j.intimp.2011.07.025
M3 - Article
C2 - 21839857
AN - SCOPUS:80055020911
SN - 1567-5769
VL - 11
SP - 1916
EP - 1924
JO - International Immunopharmacology
JF - International Immunopharmacology
IS - 11
ER -